The ovarian cancer market has transformed in recent years, driven by the expanding use of PARP inhibitors, antiangiogenic ...

Lynparza (olaparib) is a medicine that is used to treat several types of cancer including certain ovarian, breast, pancreatic, and prostate cancers.This article will focus on taking Lynparza for ...

Ovarian cancer: Deadly and difficult to diagnose. More than 20,000 people were newly diagnosed with ovarian cancer in 2021, according to the U.S. Centers for Disease Control and Prevention. In ...

Zejula (niraparib) is a targeted therapy for certain types of advanced ovarian cancer.Unlike chemotherapy, targeted therapies aim at specific proteins in cancer cells that help them to grow.This ...

Ovarian cancer starts in the ovaries and has different types, with epithelial ovarian cancer being the most common. Symptoms ...

Ovarian cancer test may not work on some Black, Native American patients. A new study focusing on the common CA-125 blood test found that some patients were 23 percent less likely to show elevated ...

The risk of developing ovarian cancer appears to jump about fourfold among women with endometriosis, compared with women who haven’t been diagnosed with the condition, a new study finds.

A U.K. lab has received a funding boost to develop the world’s first vaccine for ovarian cancer. Over 12,000 women in the U.S. die from ovarian cancer each year and the disease is often ...

Symptoms of ovarian cancer can include bloating, abdominal pain and feeling full quickly after starting to eat. AstroStar/Shutterstock If the cancer is still confined to the original site with no ...